Datasets:
id int64 | age int64 | sex string | child int64 | urban int64 | education string | bmi float64 | biomass_fuel_cooking int64 | tobacco_smoking int64 | passive_smoking int64 | occupational_dust int64 | outdoor_air_pollution int64 | childhood_respiratory_infection int64 | family_history_asthma int64 | allergic_rhinitis int64 | tb_history int64 | hiv_positive int64 | diagnosis string | severity string | spirometry_done int64 | peak_flow_done int64 | fev1_percent_predicted int64 | clinical_diagnosis_only int64 | misdiagnosed int64 | chronic_cough int64 | wheezing int64 | dyspnoea int64 | sputum_production int64 | nocturnal_symptoms int64 | exercise_limitation int64 | inhaler_prescribed int64 | inhaler_type string | inhaler_technique_correct int64 | oral_steroids int64 | oral_theophylline int64 | inhaler_affordable int64 | inhaler_available_pharmacy int64 | action_plan_given int64 | exacerbations_past_year int64 | hospitalised_exacerbation int64 | emergency_visit int64 | icu_admission int64 | oxygen_given int64 | died int64 | school_days_missed int64 | work_days_missed int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 45 | M | 0 | 0 | secondary | 14 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2 | 33 | M | 0 | 1 | none | 25.2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3 | 28 | M | 0 | 1 | secondary | 27.8 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | chronic_bronchitis | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4 | 33 | F | 0 | 0 | none | 23.1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | chronic_bronchitis | severe | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | nebuliser | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
5 | 41 | F | 0 | 0 | secondary | 31 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6 | 32 | M | 0 | 1 | secondary | 23.8 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
7 | 16 | F | 1 | 0 | secondary | 22.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
8 | 51 | F | 0 | 0 | none | 24.7 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | copd | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | nebuliser | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 5 |
9 | 85 | F | 0 | 0 | secondary | 15.7 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | combination | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 | 71 | M | 0 | 1 | tertiary | 25.2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
11 | 48 | M | 0 | 0 | tertiary | 17.4 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
12 | 71 | M | 0 | 0 | secondary | 25.2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | mild | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | combination | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 4 |
13 | 5 | F | 1 | 0 | secondary | 31.1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
14 | 25 | F | 0 | 0 | primary | 29.6 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | copd | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | nebuliser | 0 | 1 | 0 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 17 |
15 | 54 | F | 0 | 0 | none | 22.4 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | copd | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | none | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
16 | 54 | F | 0 | 0 | none | 17.8 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | copd | moderate | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | none | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
17 | 42 | M | 0 | 0 | secondary | 22.9 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | copd | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
18 | 36 | F | 0 | 1 | secondary | 26.3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
19 | 46 | M | 0 | 1 | secondary | 31.1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
20 | 52 | M | 0 | 0 | primary | 24.5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | beclomethasone_mdi | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
21 | 5 | F | 1 | 0 | secondary | 26.6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | nebuliser | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
22 | 9 | M | 1 | 1 | secondary | 15.9 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | nebuliser | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23 | 19 | M | 0 | 1 | secondary | 26.5 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | copd | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
24 | 48 | F | 0 | 0 | secondary | 24.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25 | 25 | M | 0 | 1 | none | 18.4 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
26 | 13 | F | 1 | 1 | primary | 26.8 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
27 | 72 | M | 0 | 0 | secondary | 23.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | combination | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
28 | 43 | F | 0 | 1 | primary | 16.5 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | none | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
29 | 59 | F | 0 | 0 | primary | 24.1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | chronic_bronchitis | mild | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | nebuliser | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
30 | 68 | M | 0 | 0 | secondary | 18.5 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
31 | 38 | F | 0 | 1 | primary | 16.3 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | beclomethasone_mdi | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
32 | 34 | F | 0 | 0 | secondary | 25.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | asthma | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | none | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 20 |
33 | 29 | F | 0 | 0 | primary | 25.1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | beclomethasone_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 4 |
34 | 27 | M | 0 | 0 | secondary | 23 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | copd | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 18 |
35 | 51 | M | 0 | 0 | secondary | 26 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | severe | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | beclomethasone_mdi | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
36 | 35 | M | 0 | 1 | secondary | 24.6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | mild | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
37 | 49 | F | 0 | 0 | secondary | 22 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | none | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
38 | 85 | F | 0 | 0 | none | 22.2 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | copd | moderate | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
39 | 15 | F | 1 | 0 | primary | 30.4 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
40 | 5 | F | 1 | 0 | secondary | 29.9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | combination | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
41 | 41 | F | 0 | 0 | secondary | 15.9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | beclomethasone_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
42 | 15 | F | 1 | 0 | none | 22.3 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | salbutamol_mdi | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
43 | 36 | F | 0 | 1 | none | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | chronic_bronchitis | moderate | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | beclomethasone_mdi | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
44 | 21 | M | 0 | 0 | primary | 23.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
45 | 33 | F | 0 | 0 | none | 20 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | asthma | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | nebuliser | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
46 | 5 | F | 1 | 0 | secondary | 14 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | salbutamol_mdi | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
47 | 37 | M | 0 | 1 | none | 27.4 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | copd | severe | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | none | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 13 |
48 | 56 | F | 0 | 1 | none | 24.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
49 | 73 | M | 0 | 0 | tertiary | 16 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | none | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
50 | 51 | M | 0 | 0 | none | 18.7 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | mild | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | combination | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
51 | 41 | M | 0 | 0 | secondary | 19.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
52 | 15 | M | 1 | 1 | primary | 22.9 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
53 | 27 | F | 0 | 0 | secondary | 16.7 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
54 | 38 | F | 0 | 0 | primary | 19 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | severe | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | nebuliser | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
55 | 39 | F | 0 | 1 | none | 28.1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | none | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
56 | 60 | M | 0 | 1 | none | 29.8 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | asthma | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
57 | 59 | M | 0 | 0 | secondary | 22.9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
58 | 11 | F | 1 | 0 | secondary | 23.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
59 | 30 | F | 0 | 1 | primary | 20.3 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | copd | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
60 | 21 | F | 0 | 0 | primary | 26 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | asthma_copd_overlap | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
61 | 16 | F | 1 | 0 | none | 24.6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
62 | 31 | F | 0 | 0 | primary | 28.6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | copd | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
63 | 37 | F | 0 | 1 | secondary | 25.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | nebuliser | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 20 |
64 | 41 | M | 0 | 0 | secondary | 23.4 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | beclomethasone_mdi | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 8 |
65 | 42 | M | 0 | 0 | primary | 24.2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | combination | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 6 |
66 | 12 | M | 1 | 1 | secondary | 20.2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | combination | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
67 | 53 | M | 0 | 0 | tertiary | 29.5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | chronic_bronchitis | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
68 | 28 | F | 0 | 0 | primary | 17 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
69 | 35 | F | 0 | 1 | primary | 19.2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | chronic_bronchitis | severe | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 2 |
70 | 50 | F | 0 | 0 | tertiary | 23.6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
71 | 51 | M | 0 | 0 | primary | 26.8 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | copd | severe | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | nebuliser | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
72 | 29 | M | 0 | 1 | primary | 14 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma_copd_overlap | severe | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | none | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 15 |
73 | 21 | M | 0 | 1 | primary | 25.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | nebuliser | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
74 | 55 | F | 0 | 0 | primary | 21.3 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | copd | mild | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
75 | 50 | M | 0 | 1 | tertiary | 19.3 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | copd | mild | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | salbutamol_mdi | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
76 | 43 | M | 0 | 1 | secondary | 21.9 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | nebuliser | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
77 | 79 | F | 0 | 0 | none | 16.6 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | mild | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | nebuliser | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
78 | 45 | M | 0 | 0 | secondary | 14 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
79 | 46 | F | 0 | 1 | secondary | 15.1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | asthma | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | none | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
80 | 41 | F | 0 | 0 | primary | 25 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | mild | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 7 |
81 | 5 | M | 1 | 0 | tertiary | 22.1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
82 | 54 | M | 0 | 1 | secondary | 31 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | severe | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | beclomethasone_mdi | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 34 |
83 | 24 | M | 0 | 1 | primary | 14 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | chronic_bronchitis | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | salbutamol_mdi | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
84 | 22 | M | 0 | 0 | tertiary | 24.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | copd | severe | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | salbutamol_mdi | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
85 | 27 | M | 0 | 1 | secondary | 26.3 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | severe | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | salbutamol_mdi | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
86 | 59 | F | 0 | 0 | tertiary | 20.3 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | copd | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
87 | 49 | M | 0 | 0 | none | 26.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 16 |
88 | 32 | F | 0 | 0 | primary | 14 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
89 | 57 | F | 0 | 0 | secondary | 28 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | copd | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
90 | 54 | M | 0 | 1 | primary | 19.6 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | copd | mild | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | none | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 19 |
91 | 29 | F | 0 | 1 | secondary | 18.2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | combination | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 14 |
92 | 48 | M | 0 | 0 | secondary | 25.5 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
93 | 55 | F | 0 | 0 | secondary | 25 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | beclomethasone_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
94 | 18 | F | 0 | 0 | secondary | 22.9 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | asthma | moderate | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | beclomethasone_mdi | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 16 |
95 | 10 | F | 1 | 0 | primary | 19.5 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | mild | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | salbutamol_mdi | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 17 | 0 |
96 | 66 | F | 0 | 0 | secondary | 28.5 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | copd | severe | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | salbutamol_mdi | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
97 | 53 | F | 0 | 1 | none | 26.4 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | copd | moderate | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | none | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
98 | 54 | M | 0 | 1 | primary | 29.8 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | salbutamol_mdi | 1 | 0 | 0 | 0 | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 7 |
99 | 60 | F | 0 | 1 | secondary | 23.7 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | copd | mild | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | salbutamol_mdi | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
100 | 73 | F | 0 | 0 | primary | 32.7 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | asthma | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | salbutamol_mdi | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 28 |
Asthma & COPD Dataset
Abstract
This dataset provides 30,000 simulated chronic respiratory disease records (10,000 per scenario) from sub-Saharan Africa. Each record contains 45+ variables including diagnosis, risk factors, symptoms, spirometry, inhaler access, exacerbations, and outcomes. Three settings: urban respiratory clinic (0.81% mortality), district hospital (1.71%), and rural health centre (3.82%).
1. Introduction
Asthma and COPD are under-recognised, under-diagnosed, and under-treated in SSA. Over 90% of rural households depend on biomass fuel for cooking — the leading risk factor for chronic respiratory disease. Spirometry is rarely available, inhaler access is extremely limited outside urban areas, and only ~35% of users have correct inhaler technique.
This dataset is entirely simulated. It must not be used for clinical decision-making.
2. Methodology
2.1 Parameterization
| Parameter | Value | Source |
|---|---|---|
| Biomass fuel use (rural) | ~90% | Nature 2011 |
| Inhaler technique correct | ~35% | PMC 2025 |
| COPD neglected in SSA | Yes | PubMed 2018 |
| Household air pollution | #1 risk | PMC 2025 |
| Asthma underdiagnosis | Common | PubMed 2017 |
2.2 Scenario Design
| Scenario | Spirometry | Inhalers | O2 | Mortality |
|---|---|---|---|---|
| Urban clinic | Yes | Yes | Yes | 0.81% |
| District hospital | No | Yes | Yes | 1.71% |
| Rural HC | No | No | No | 3.82% |
3. Schema
| Column | Type | Description |
|---|---|---|
| id | int | Unique identifier |
| age | int | Patient age |
| diagnosis | categorical | asthma / copd / overlap / chronic_bronchitis |
| severity | categorical | mild / moderate / severe |
| biomass_fuel_cooking | binary | Uses biomass fuel |
| tobacco_smoking | binary | Current smoker |
| spirometry_done | binary | Spirometry performed |
| fev1_percent_predicted | int | FEV1% predicted |
| inhaler_prescribed | binary | Inhaler prescribed |
| inhaler_technique_correct | binary | Correct technique |
| exacerbations_past_year | int | Annual exacerbations |
| hospitalised_exacerbation | binary | Hospitalised |
| died | binary | Died |
4. Validation
Key validation checks:
- Mortality gradient: 0.81% → 1.71% → 3.82% ✓
- Biomass fuel: ~70% overall ✓
- Inhaler access: 75% urban → 0% rural ✓
- Inhaler technique: ~35% correct ✓
- Spirometry: only at specialist centres ✓
- Asthma ~50% of diagnoses ✓
5. Usage
from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/asthma-copd-respiratory", "district_hospital")
df = dataset["train"].to_pandas()
6. Limitations
- Simulated: Not from real respiratory registries.
- No lung function curves: No flow-volume loops.
- No allergen data: No skin prick/IgE testing.
- Simplified: No detailed pharmacotherapy.
- Cross-sectional: No longitudinal lung function decline.
7. References
- PMC (2025). Household air pollution and respiratory health Africa.
- PMC (2022). Ambient air pollution and NCRDs SSA.
- Nature (2011). Asthma/COPD in SSA, biomass fuel.
- PubMed (2011). Asthma/COPD under-treated in SSA.
- PubMed (2017). Biomass fuel and asthma severity Nigeria.
- PubMed (2018). COPD neglected in LMICs.
- PubMed (2024). CHEST-Africa respiratory observatory.
Citation
@dataset{esa_asthma_copd_2025,
title={Asthma and COPD Dataset},
author={Electric Sheep Africa},
year={2025},
publisher={Hugging Face},
url={https://huggingface.co/datasets/electricsheepafrica/asthma-copd-respiratory}
}
License
- Downloads last month
- 56